Profound Bio

Developer of novel therapies for the treatment of cancer

placeWoodinville, Washington, United States calendar_todayFounded 2018 language profoundbio.com

Registered entities

Investor mix

20 investors on record; lead investors include LYFE Capital, LAV Asset Management, Nextech Invest, Janus Henderson Investors; 4 have since exited.

Investor typeCountShare
Venture capital1155%
Private equity420%
Bank & private debt210%
Other / undisclosed315%
Coming soon